Rational structure-guided design of a blood stage malaria vaccine immunogen presenting a single epitope from PfRH5.
Journal article
Harrison TE. et al, (2024), EMBO Mol Med
Synergistic blockade of TIGIT and PD-L1 increases type-1 inflammation and improves parasite control during murine blood-stage Plasmodium yoelii non-lethal infection.
Journal article
Dookie RS. et al, (2024), Infection and immunity
Analysis of the diverse antigenic landscape of the malaria protein RH5 identifies a potent vaccine-induced human public antibody clonotype.
Journal article
Barrett JR. et al, (2024), Cell
Natural malaria infection elicits rare but potent neutralizing antibodies to the blood-stage antigen RH5.
Journal article
Wang LT. et al, (2024), Cell
Preclinical development of a stabilized RH5 virus-like particle vaccine that induces improved antimalarial antibodies.
Journal article
King LDW. et al, (2024), Cell reports. Medicine, 5
Blood-stage malaria vaccine candidate RH5.1/Matrix-M in healthy Tanzanian adults and children; an open-label, non-randomised, first-in-human, single-centre, phase 1b trial
Journal article
Silk SE. et al, (2024), The Lancet Infectious Diseases
Evaluation of the precision of the Plasmodium knowlesi growth inhibition assay for Plasmodium vivax Duffy-binding protein-based malaria vaccine development.
Journal article
Mertens JE. et al, (2024), Vaccine
Analyses of human vaccine-specific circulating and bone marrow-resident B cell populations reveal benefit of delayed vaccine booster dosing with blood-stage malaria antigens
Journal article
Barrett JR. et al, (2024), Frontiers in Immunology, 14
Cellular iron governs the host response to malaria.
Journal article
Wideman SK. et al, (2023), PLoS pathogens, 19
Erythrocyte invasion-neutralising antibodies prevent Plasmodium falciparum RH5 from binding to basigin-containing membrane protein complexes.
Journal article
Jamwal A. et al, (2023), eLife, 12
Respiratory mucosal immune memory to SARS-CoV-2 after infection and vaccination.
Journal article
Mitsi E. et al, (2023), Nature communications, 14
Superior antibody immunogenicity of a viral-vectored RH5 blood-stage malaria vaccine in Tanzanian infants as compared to adults
Journal article
Silk SE. et al, (2023), Med, 4, 668 - 686.e7
The dual action of human antibodies specific to Plasmodium falciparum PfRH5 and PfCyRPA: Blocking invasion and inactivating extracellular merozoites.
Journal article
Weiss GE. et al, (2023), PLoS pathogens, 19
A systematic analysis of the human immune response to Plasmodium vivax
Journal article
Bach FA. et al, (2023), Journal of Clinical Investigation
Assessment of precision in growth inhibition assay (GIA) using human anti-PfRH5 antibodies.
Journal article
Miura K. et al, (2023), Malaria journal, 22
Delayed boosting improves human antigen-specific Ig and B cell responses to the RH5.1/AS01B malaria vaccine
Journal article
Nielsen CM. et al, (2023), JCI Insight, 8
Production of a high purity, C‐tagged hepatitis B surface antigen fusion protein VLP vaccine for malaria expressed in Pichia pastoris under cGMP conditions
Journal article
Mukhopadhyay E. et al, (2022), Biotechnology and Bioengineering, 119, 2784 - 2793
Modular capsid decoration boosts adenovirus vaccine-induced humoral immunity against SARS-CoV-2.
Journal article
Dicks MDJ. et al, (2022), Molecular therapy : the journal of the American Society of Gene Therapy
Streptococcus pneumoniae colonization associates with impaired adaptive immune responses against SARS-CoV-2.
Journal article
Mitsi E. et al, (2022), The Journal of clinical investigation, 132
Heterotypic interactions drive antibody synergy against a malaria vaccine candidate.
Journal article
Ragotte RJ. et al, (2022), Nature communications, 13